Patricio Polanco, M.D.

Patricio Polanco, M.D., is an Associate Professor in the Division of Surgical Oncology in the Department of Surgery at UT Southwestern Medical Center. 

He is gastrointestinal surgical oncologist with vast expertise in minimally invasive/robotic pancreas and liver surgery. Dr. Polanco serves as the Director of the Robotic Surgery Training Program at UT Southwestern as well as Co-Director for the Pancreatic Cancer Program and the Pancreatic Cancer Prevention Clinic. Dr. Polanco also leads the Peritoneal Surface Malignancies and HIPEC (Hyperthermic Intraperitoneal Chemotherapy) program at UT Southwestern, NCI-Comprehensive Simmons Cancer Center. 

A native of Peru, Dr. Polanco graduated as valedictorian of Universidad de San Martin de Porres Medical School. After completing his surgical training in Lima, Peru, he moved to the United States, where he completed a postdoctoral research fellowship and a general surgery residency at the University of Pittsburgh. During his training, Dr. Polanco received several prestigious accolades, including the Alpha Omega Alpha-Honor Medical Society, the Charles C. Moore Teaching Award at the University of Pittsburgh School of Medicine, and the Gold Foundation Humanism and Excellence in Teaching Award. He later pursued a Complex Surgical Oncology Fellowship at University of Pittsburgh Medical Center. 

A doubled board-certified surgeon by the American Board of Surgery (General Surgery and Complex General Surgical Oncology), Dr. Polanco joined the UT Southwestern faculty in 2014. 

Dr. Polanco research interests includes health services research, disparities, and surgical outcomes in HPB malignancies and pancreatic cancer. He is also the site principal investigator for several clinical trials for pancreatic cancer. His research has been presented in national and international meetings and has published over 100 peer-reviewed article is several surgical and cancer journals.

Dr. Polanco has served in several committees and leadership positions of academic associations including the Americas Hepato-Pancreato-Biliary Association, Society of Surgical Oncology, American College of Surgeons, among others. He also serves in the Pancreatic Cancer and the Malignant Peritoneal Mesothelioma expert panel for the National Comprehensive Cancer Network (NCCN) guidelines.  Dr. Polanco's commitment to the advancement of medical knowledge extends globally, as he has trained and guided several international surgeons in establishing robotic surgery HPB programs. Furthermore, his extensive experience in medical mission trips to Central and South America highlights his dedication to providing healthcare access to underserved populations.

Dr. Polanco was included in D Magazine's Best Doctors list for 2019 to 2023.